Latest reported quarter: Q3, ended Jul 2026
Quarter 2026/Q3
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $210.50M | $216.00M | $209.60M | $844.60M | $228.90M |
| Total Operating Revenue | $210.50M | $216.00M | $209.60M | $844.60M | $228.90M |
| Cost of Revenue | $133.80M | $143.40M | $139.80M | $554.10M | $151.10M |
| Gross Profit | $76.70M | $72.60M | $69.80M | $290.50M | $77.80M |
| Operating Expense | $53.90M | $58.20M | $54.40M | $224.40M | $58.20M |
| Selling and Admin Expenses | $30.60M | $36.00M | $32.70M | $133.30M | $34.00M |
| Research & Development | $23.30M | $22.20M | $21.70M | $91.10M | $24.20M |
| Operating Profit | $22.80M | $14.40M | $15.40M | $66.10M | $19.60M |
| Net Non-Operating Interest Income (Expense) | -$4.90M | -$7.40M | -$7.30M | -$27.00M | -$7.00M |
| Non-Operating Interest Income | $900,000.00 | $400,000.00 | $600,000.00 | $8.50M | $1.00M |
| Non-Operating Interest Expense | $5.50M | $7.50M | $7.40M | $32.70M | $7.60M |
| Total Other Finance Costs | $300,000.00 | $300,000.00 | $500,000.00 | $2.80M | $400,000.00 |
| Other Income (Expense) | -$1.70M | -$13.40M | -$4.30M | -$98.30M | $1.50M |
| Special Income (Charges) | $0.00 | -$9.40M | – | -$93.90M | $100,000.00 |
| -Less:Impairment of Capital Assets | $0.00 | – | – | $93.90M | $0.00 |
| Other Non-Operating Income (Expenses) | -$1.70M | -$4.00M | -$4.30M | $900,000.00 | $6.70M |
| Pretax Profit | $16.20M | -$6.40M | $3.80M | -$59.20M | $14.10M |
| Tax | $300,000.00 | $1.60M | $1.40M | $10.70M | $1.90M |
| Net Profit | $15.90M | -$8.00M | $2.40M | -$69.90M | $12.20M |
| Profit from Continuing Operations | $15.90M | -$8.00M | $2.40M | -$69.90M | $12.20M |
| Minority Interests | $200,000.00 | $100,000.00 | $100,000.00 | $400,000.00 | $0.00 |
| Net Income to Parent Company | $15.70M | -$8.10M | $2.30M | -$70.30M | $12.20M |
| Net Income to Common Stockholders | $15.70M | -$8.10M | $2.30M | -$70.30M | $12.20M |
| Basic EPS | $0.37 | -$0.19 | $0.06 | -$1.70 | $0.29 |
| Diluted EPS | $0.37 | -$0.19 | $0.05 | -$1.70 | $0.29 |
| -Less:Other Special Charges | – | $9.40M | – | – | – |
| Gain on Sale of Security | – | – | – | -$3.00M | – |
| Earnings from Equity Interest | – | – | – | -$2.30M | – |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | – |
| -Less:Write Off | – | – | – | $0.00 | – |
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.10B | $1.09B | $1.10B | $1.11B | $1.11B |
| Total Current Assets | $633.10M | $625.60M | $633.60M | $641.80M | $641.80M |
| Cash and Cash Equivalents & Short-Term Investments | $99.20M | $88.30M | $125.60M | $155.10M | $155.10M |
| -Cash and Cash Equivalents | $99.20M | $85.30M | $119.50M | $145.00M | $145.00M |
| -Short Term Investments | $0.00 | $3.00M | $6.10M | $10.10M | $10.10M |
| Receivables | $144.70M | $148.10M | $146.50M | $156.60M | $156.60M |
| -Accounts Receivable | $144.70M | $148.10M | $146.50M | $156.60M | $156.60M |
| Inventory | $346.70M | $346.70M | $328.00M | $299.40M | $299.40M |
| Other Current Assets | $42.50M | $42.50M | $33.50M | $30.70M | $30.70M |
| Total Non-Current Assets | $466.90M | $463.80M | $464.40M | $465.60M | $465.60M |
| Net PPE | $197.00M | $192.40M | $189.30M | $187.20M | $187.20M |
| -Gross PPE | $197.00M | $192.40M | $189.30M | $458.20M | $458.20M |
| Investments and Advances | $20.20M | $20.00M | $21.30M | $24.50M | $24.50M |
| -Long Term Equity Investment | $20.20M | $20.00M | $21.30M | $24.50M | $24.50M |
| Goodwill and Other Intangible Assets | $210.00M | $211.00M | $213.10M | $212.40M | $212.40M |
| -Goodwill | $197.60M | $197.80M | $198.40M | $198.40M | $198.40M |
| -Other Intangible Assets | $12.40M | $13.20M | $14.70M | $14.00M | $14.00M |
| Non-Current Deferred Assets | $2.00M | $2.90M | $2.90M | $2.90M | $2.90M |
| Other Non-Current Assets | $37.70M | $37.50M | $37.80M | $38.60M | $38.60M |
| Total Liabilities | $589.50M | $601.30M | $607.20M | $620.80M | $620.80M |
| Total Current Liabilities | $187.40M | $195.30M | $163.00M | $187.20M | $187.20M |
| Payables | $85.30M | $97.10M | $81.80M | $75.20M | $75.20M |
| -Accounts Payable | $83.50M | $96.40M | $78.90M | $69.90M | $69.90M |
| -Total Tax Payable | $1.80M | $700,000.00 | $2.90M | $5.30M | $5.30M |
| Current Accrued Expenses | $17.90M | $17.10M | $22.40M | $29.70M | $29.70M |
| Short-Term Debt and Capital Lease Obligation | $22.70M | $23.30M | $6.00M | $5.90M | $5.90M |
| -Current Debt | $18.20M | $18.60M | $1.40M | $1.50M | $1.50M |
| -Current Capital Lease Obligation | $4.50M | $4.70M | $4.60M | $4.40M | $4.40M |
| Current Deferred Liabilities | $8.60M | $14.50M | $12.40M | $13.00M | $13.00M |
| Other Current Liabilities | $16.00M | $12.60M | $11.10M | $20.00M | $20.00M |
| Total Non-Current Liabilities | $402.10M | $406.00M | $444.20M | $433.60M | $433.60M |
| Long Term Debt and Capital Lease Obligation | $350.90M | $352.00M | $389.50M | $390.00M | $390.00M |
| -Long Term Debt | $328.90M | $329.00M | $366.20M | $366.00M | $366.00M |
| -Long Term Capital Lease Obligation | $22.00M | $23.00M | $23.30M | $24.00M | $24.00M |
| Non-Current Deferred Liabilities | $4.50M | $5.80M | $5.50M | $5.50M | $5.50M |
| Other Non-Current Liabilities | $46.70M | $48.20M | $49.20M | $29.60M | $29.60M |
| Total Equity | $510.50M | $488.10M | $490.80M | $486.60M | $486.60M |
| Stockholders' Equity | $496.60M | $474.20M | $476.90M | $472.60M | $472.60M |
| Capital Stock | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Common Stock | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $495.10M | $491.10M | $485.60M | $483.30M | $483.30M |
| Retained Earnings | $4.00M | -$11.70M | -$3.60M | -$5.90M | -$5.90M |
| Gains/Losses Not Affecting Retained Earnings | -$2.90M | -$5.60M | -$5.50M | -$5.20M | -$5.20M |
| Minority Interests | $13.90M | $13.90M | $13.90M | $14.00M | $14.00M |
| -Accumulated Depreciation | – | – | – | -$271.00M | -$271.00M |
| Long Term Accounts Payable and Other Payables | – | – | – | $2.30M | $2.30M |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
| Employee Benefits | – | – | – | $6.20M | $6.20M |
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $21.00M | -$1.50M | -$16.10M | $41.70M | $7.90M |
| Net cash flow from continuing operations | $21.00M | -$1.50M | -$16.10M | $41.70M | $7.90M |
| Net Income from Continuing Operations | $15.90M | -$8.00M | $2.40M | -$69.90M | $12.20M |
| Gain/Loss from Continuing Operations | -$200,000.00 | $10.70M | $3.20M | $2.70M | $100,000.00 |
| Depreciation & Depletion & Amortization | $7.00M | $6.80M | $6.80M | $27.20M | $6.70M |
| Deferred Tax | -$400,000.00 | -$100,000.00 | $600,000.00 | -$500,000.00 | $2.70M |
| Other Non-Cash Items | $800,000.00 | $1.90M | $1.00M | $900,000.00 | -$1.50M |
| Change in Working Capital | -$7.50M | -$18.40M | -$35.00M | -$31.40M | -$16.50M |
| -Change in Receivables | $3.20M | -$1.10M | $8.90M | $100,000.00 | -$20.10M |
| -Change in Inventory | -$1.50M | -$21.80M | -$30.10M | -$39.90M | -$2.30M |
| -Change in Prepaid Assets | $2.20M | -$7.40M | -$2.10M | -$3.60M | $1.70M |
| -Change in Payables and Accrued Expense | -$5.90M | $9.80M | -$11.70M | $6.30M | $6.10M |
| -Change In Other Working Capital | -$5.50M | – | – | $5.70M | -$1.90M |
| Net cash flow from investing | -$6.30M | -$3.10M | -$7.70M | $10.30M | -$700,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$6.30M | -$3.10M | -$7.70M | $10.30M | -$700,000.00 |
| Net PPE Purchase and Sale | -$9.00M | -$6.20M | -$10.70M | -$22.90M | -$5.60M |
| Net Investment Purchase and Sale | $3.00M | $3.10M | $4.00M | $34.00M | $5.40M |
| Net Other Investing Changes | -$300,000.00 | $0.00 | -$1.00M | -$800,000.00 | -$500,000.00 |
| Financing Cash Flow | -$1.20M | -$29.30M | -$1.60M | -$75.90M | $1.10M |
| Net Cash Flow from Continuing Financing Activities | -$1.20M | -$29.30M | -$1.60M | -$75.90M | $1.10M |
| Net Issuance Payments Of Debt | -$400,000.00 | -$23.20M | $0.00 | -$75.00M | -$400,000.00 |
| Proceeds from Stock Option Exercised | $0.00 | – | – | $3.30M | $1.60M |
| Net Other Financing Charges | -$800,000.00 | -$7.80M | -$1.60M | -$4.20M | -$100,000.00 |
| Ending Cash Balance | $101.10M | $87.70M | $121.70M | $147.10M | $147.10M |
| Net Change in Cash | $13.50M | -$33.90M | -$25.40M | -$23.90M | $8.30M |
| Beginning Cash Balance | $87.70M | $121.70M | $147.10M | $170.40M | $138.50M |
| Effect of Exchange Rate Changes | -$100,000.00 | – | – | $600,000.00 | $300,000.00 |
| Free Cash Flow | $12.00M | -$7.70M | -$26.80M | $18.80M | $2.30M |
| Net Business Purchase and Sale | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on VREX.